UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 64

Sortiert nach

P396: The need for a longitudinal digital health platform to implement large scale genomic programs

Genetics in Medicine Open, 2023, Vol.1 (1), p.100432, Article 100432

2023

Link zum Volltext

Verfügbarkeit prüfen

Genotype–phenotype associations among panel-based TP53+ subjects

Genetics in medicine, 2019-11, Vol.21 (11), p.2478-2484

2019

Link zum Volltext

Verfügbarkeit prüfen

An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance

Npj genomic medicine, 2022-06, Vol.7 (1), p.35-35, Article 35

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-09-19: Inequitable access to genetic testing leads to missed screening and prevention opportunities for individuals at risk for hereditary breast and ovarian cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-09-19

2022

Link zum Volltext

Verfügbarkeit prüfen

BAP1 tumor predisposition syndrome: Preliminary data from a laboratory-based multigene panel testing cohort

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.490-490

2017

Link zum Volltext

Verfügbarkeit prüfen

Closing the gap: Trends in inconclusive rates on hereditary cancer testing across racial/ethnic groups

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.10525-10525

2021

Link zum Volltext

Verfügbarkeit prüfen

EPID-16. HEREDITARY BRAIN TUMORS ARE MORE COMMON THAN YOU THINK: GERMLINE MUTATIONS IN BENIGN AND MALIGNANT PRIMARY BRAIN TUMORS

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi72-vi72

2017

Link zum Volltext

Verfügbarkeit prüfen

Increased detection of germline cancer susceptibility mutations subsequent to tumor profiling

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e13613-e13613

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-09-03: Pathogenic variants among female breast cancer patients with a subsequent cancer demonstrate preventable cancer burden

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-09-03

2022

Link zum Volltext

Verfügbarkeit prüfen

MP34-18 PERFORMANCE OF MULTIGENE PANEL TESTING IN HEREDITARY PROSTATE CANCER

The Journal of urology, 2018-04, Vol.199 (4), p.e444-e445

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract P6-08-35: Impact of multigene panel testing on medical management: Preliminary pre- and post-test clinician survey results

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P6-P6-08-35

2020

Link zum Volltext

Verfügbarkeit prüfen

eP075 - Multi-gene panel testing results prompt frequent and guideline adherent changes to cancer risk management recommendations based on clinician report

Molecular genetics and metabolism, 2021-04, Vol.132, p.S51-S52

2021

Link zum Volltext

Verfügbarkeit prüfen

Divergent payor medical policy leads to gross disparities in access to hereditary breast and ovarian cancer genetic testing

Molecular genetics and metabolism, 2021-04, Vol.132, p.S54

2021

Link zum Volltext

Verfügbarkeit prüfen

Multi-gene panel testing results prompt frequent and guideline adherent changes to cancer risk management recommendations based on clinician report

Molecular genetics and metabolism, 2021-04, Vol.132, p.S51-S52

2021

Link zum Volltext

Verfügbarkeit prüfen

Universal multi-gene panel testing for individuals with pheochromocytomas and paragangliomas

Molecular genetics and metabolism, 2021-04, Vol.132, p.S54-S55

2021

Link zum Volltext

Verfügbarkeit prüfen

eP078 - Divergent payor medical policy leads to gross disparities in access to hereditary breast and ovarian cancer genetic testing

Molecular genetics and metabolism, 2021-04, Vol.132, p.S54-S54

2021

Link zum Volltext

Verfügbarkeit prüfen

eP080 - Universal multi-gene panel testing for individuals with pheochromocytomas and paragangliomas

Molecular genetics and metabolism, 2021-04, Vol.132, p.S54-S55

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract PD10-07: Rna genetic testing improves detection of patients with hereditary breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PD10-07-PD10-07

2021

Link zum Volltext

Verfügbarkeit prüfen

Su1777 - Inherited Susceptibility to Biliary Tract and Ampullary Cancers

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S555-S555

2017

Link zum Volltext

Verfügbarkeit prüfen

MP33-15 GENDER DISPARITY: OVERLOOKING HEREDITARY PROSTATE CANCER AND IMPLICATIONS FOR UROLOGY PRACTICE

The Journal of urology, 2017-04, Vol.197 (4), p.e423-e423

2017

Link zum Volltext

Verfügbarkeit prüfen

Gender disparity: Overlooking hereditary prostate cancer

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.85-85

2017

Link zum Volltext

Verfügbarkeit prüfen

Importance of genetic testing for patients with multiple colorectal cancer primaries

Journal of clinical oncology, 2017-02, Vol.35 (4_suppl), p.528-528

2017

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.10595-10595

2021

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interception

Breast cancer research and treatment, 2023-07, Vol.200 (1), p.73-73

2023

Link zum Volltext

Verfügbarkeit prüfen

1066 - Phenotypic Expression of Cdh1 Germline Mutations Unselected for Hereditary Diffuse Gastric Cancer

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-204-S-204

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 64

Suche als RSS-Feed

Aktive Filter

ThemaMutation

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Englisch
(64)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

P396: The need for a longitudinal digital health platform to implement large scale genomic programs

Genotype–phenotype associations among panel-based TP53+ subjects

An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance

Abstract P2-09-19: Inequitable access to genetic testing leads to missed screening and prevention opportunities for individuals at risk for hereditary breast and ovarian cancer

BAP1 tumor predisposition syndrome: Preliminary data from a laboratory-based multigene panel testing cohort

Closing the gap: Trends in inconclusive rates on hereditary cancer testing across racial/ethnic groups

EPID-16. HEREDITARY BRAIN TUMORS ARE MORE COMMON THAN YOU THINK: GERMLINE MUTATIONS IN BENIGN AND MALIGNANT PRIMARY BRAIN TUMORS

Increased detection of germline cancer susceptibility mutations subsequent to tumor profiling

Abstract P2-09-03: Pathogenic variants among female breast cancer patients with a subsequent cancer demonstrate preventable cancer burden

MP34-18 PERFORMANCE OF MULTIGENE PANEL TESTING IN HEREDITARY PROSTATE CANCER

Abstract P6-08-35: Impact of multigene panel testing on medical management: Preliminary pre- and post-test clinician survey results

eP075 - Multi-gene panel testing results prompt frequent and guideline adherent changes to cancer risk management recommendations based on clinician report

Divergent payor medical policy leads to gross disparities in access to hereditary breast and ovarian cancer genetic testing

Multi-gene panel testing results prompt frequent and guideline adherent changes to cancer risk management recommendations based on clinician report

Universal multi-gene panel testing for individuals with pheochromocytomas and paragangliomas

eP078 - Divergent payor medical policy leads to gross disparities in access to hereditary breast and ovarian cancer genetic testing

eP080 - Universal multi-gene panel testing for individuals with pheochromocytomas and paragangliomas

Abstract PD10-07: Rna genetic testing improves detection of patients with hereditary breast cancer

Su1777 - Inherited Susceptibility to Biliary Tract and Ampullary Cancers

MP33-15 GENDER DISPARITY: OVERLOOKING HEREDITARY PROSTATE CANCER AND IMPLICATIONS FOR UROLOGY PRACTICE

Gender disparity: Overlooking hereditary prostate cancer

Importance of genetic testing for patients with multiple colorectal cancer primaries

Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers

Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interception

1066 - Phenotypic Expression of Cdh1 Germline Mutations Unselected for Hereditary Diffuse Gastric Cancer

Aktive Filter

Suchergebnisse filtern